Patents by Inventor Gregory Peckham

Gregory Peckham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS
    Publication number: 20120077812
    Abstract: The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
    Type: Application
    Filed: November 30, 2011
    Publication date: March 29, 2012
    Inventors: JING FANG, Jun Tang, Andrew J. Carpenter, Gregory Peckham, Christopher R. Conlee, Kien S. Du, Subba Reddy Katamreddy
  • Bicyclic compounds and use as antidiabetics
    Patent number: 8101634
    Abstract: The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
    Type: Grant
    Filed: December 5, 2007
    Date of Patent: January 24, 2012
    Assignee: GlaxoSmithKline LLC
    Inventors: Jing Fang, Jun Tang, Andrew J Carpenter, Gregory Peckham, Christopher R Conlee, Kien S Du, Subba Reddy Katamreddy
  • Chemical Compounds and Uses
    Publication number: 20110124652
    Abstract: The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
    Type: Application
    Filed: July 28, 2009
    Publication date: May 26, 2011
    Inventors: Andrew J. Carpenter, Jing Fang, Gregory Peckham
  • BICYCLIC COMPOUNDS AND USE AS ANTIDIABETICS
    Publication number: 20100029650
    Abstract: The present invention relates to novel compounds that are useful in the treatment of metabolic disorders, particularly type II diabetes mellitus and related disorders, and also to the methods for the making and use of such compounds.
    Type: Application
    Filed: December 5, 2007
    Publication date: February 4, 2010
    Inventors: Jing Fang, Jun Tang, Andrew J. Carpenter, Gregory Peckham, Christopher R. Conlee, Kien S. Du, Subba Reddy Katamreddy
  • Fused pyrazole derivatives being protein kinase inhibitors
    Patent number: 7166597
    Abstract: Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R1, R2, and R4 are various substituent groups, are protein kinase inhibitors
    Type: Grant
    Filed: August 22, 2001
    Date of Patent: January 23, 2007
    Assignee: Glaxo Group Limited
    Inventors: Michael John Alberti, Ian Robert Baldwin, Mui Cheung, Stuart Cockerill, Stephen Flack, Philip Anthony Harris, David Kendall Jung, Gregory Peckham, Michael Robert Peel, Jennifer Gabriel Badiang, Kirk Stevens, James Marvin Veal
  • Crystal structure of liganded cFMS kinase domain
    Publication number: 20070010540
    Abstract: A crystal structure of the cfms kinase domain, co-crystal structure with a bound small molecule, as well as methods of using the same in the discovery of cfms inhibitors and in the treatment of diseases mediated by inappropriate cfms activity.
    Type: Application
    Filed: May 9, 2006
    Publication date: January 11, 2007
    Inventors: Lisa Shewchuk, Anne Hassell, William Holmes, James Veal, Holly Emerson, David Musso, Stanley Chamberlain, Gregory Peckham
  • Heterocyclic mchr1 antagoists
    Publication number: 20060194871
    Abstract: This invention relates to novel heterocycles which are antagonists at the melanin-concentrating hormone receptor 1 (MCHR1), also referred to as 11 CBy, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in medicines.
    Type: Application
    Filed: April 6, 2004
    Publication date: August 31, 2006
    Inventors: Kevin Barvian, Andrew Carpenter, Joel Cooper, Paul Feldman, Dulce Garrido, Yu Guo, Anthony Handlon, Donald Hertzog, Clifton Hyman, Andrew Peat, Gregory Peckham, Jason Speake, William Swain, Francis Tavares, Huiqiang Zhou
  • Fused pyrazole derivatives bieng protein kinase inhibitors
    Publication number: 20040053942
    Abstract: Compounds of Formula (I): salts or solvates or physiologically functional derivatives thereof, wherein Z is CH or N, and R1, (R2, and R4 are various substituent groups, are protein kinase inhibitors.
    Type: Application
    Filed: July 7, 2003
    Publication date: March 18, 2004
    Inventors: Michael John Alberti, Ian Baldwin, Mui Cheung, Stuart Cockerill, Philip Harris, David Jung, Gregory Peckham, Michael Peel, Jennifer Badiang, Kirk Stevens, James Veal